OpenAlex
PricingAboutJobs
Log inGet started
Work

Addition of Either Lonidamine or Granulocyte Colony-Stimulating Factor Does Not Improve Survival in Early Breast Cancer Patients Treated With High-Dose Epirubicin and Cyclophosphamide

HTML

Year: 2003
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Journal of Clinical Oncology
DOI: 10.1200/jco.2003.03.034
Authors: Paola Papaldo, Massimo Lopez, Enrico Cortesi, Eugenio Cammilluzzi, Mauro Antimi, Edmondo Terzoli, Giuseppe Lepidini, Patrizia Vici, Carlo Barone, Gianluigi Ferretti, Serena Di Cosimo, Cecilia Nisticò, Paolo Carlini, Francesca Conti, Luigi Di Lauro, Claudio Botti, Carlo Vitucci, Alessandra Fabi, Diana Giannarelli, Paolo Marolla
Institutions: Ospedale San Filippo Neri, St. Eugenio Hospital, Instituto Nazionale Tumori Regina Elena, Sapienza University of Rome, Fondazione IRCCS Istituto Nazionale dei Tumori
Language: English

Topic: Breast Cancer Treatment Studies
Subfield: Cancer Research
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: early breast cancer, lonidamine, granulocyte colony-stimulating factor, high-dose epirubicin, cyclophosphamide, disease-free survival, overall survival, hematologic toxicity
SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute
OpenAlex ID: W2139754445
FWCI: 1.917
Cites: 37
Cited by: 84
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security